Anti-Infectives Drug Development Summit - April 2021 - Digital Event
Evvnt Promotion / evvnt
Archivo
20.04.2021 - 22.04.2021 Online
Time: 08:15 - 17:00
Temas de la conferencia
Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.
Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Speakers: Ercem Atillasoy Chief Regulatory and Safety Officer AlloVir, Martin Everett Chief Scientific Officer AntaBio, Glenn Dale Chief Development Officer BioVersys and more.
Speakers: Ercem Atillasoy Chief Regulatory and Safety Officer AlloVir, Martin Everett Chief Scientific Officer AntaBio, Glenn Dale Chief Development Officer BioVersys and more.
Información e inscripción:
https://go.evvnt.com/717995-2?pid=4832
Mr. Customer Service
Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
Conference Only: USD 1799.0, Conference + 1 Workshop: USD 2098.0, Conference + 2 Workshops: USD 2397.0
Conference Only: USD 1799.0, Conference + 1 Workshop: USD 2098.0, Conference + 2 Workshops: USD 2397.0
Los participantes esperaban
1000
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
